|Articles|December 23, 2022
News Roundup: December 19 to December 23
Author(s)Lauren Biscaldi, MS
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
FDA Approves First-In-Class Twice-Yearly Treatment for HIV
Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.
CBD May Help Mitigate Opioid Withdrawal Symptoms
In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.
Examining Rates of COVID-19 Rebound With Antiviral Therapies
Research tells a different story than recent news headlines.
Copay Caps for Insulin Lower Total Spending for Medicare Beneficiaries
The Medicare Part D Senior Savings Model—a CMS effort to test $35 copays for insulin—led to lowered total costs for beneficiaries.
How General Vaccine Hesitancy Is Impacting Teen COVID-19 Vaccination Rates
The COVID-19 vaccine rate for teenagers lags behind vaccination rates for adults. Does parental hesitancy for vaccines in general play a role?
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Executive Order Calls for Realignment of Childhood Vaccines
2
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
3
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
4
Q&A: Pharmacists Can Address ADA Standards Across All Settings
5